JAKAVI for Myelofibrosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 98 adverse event reports in the FDA FAERS database where JAKAVI was used for Myelofibrosis.
Most Reported Side Effects for JAKAVI
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 30 | 20.3% | 30 | 11 |
| Platelet count decreased | 22 | 14.9% | 7 | 9 |
| Anaemia | 17 | 11.5% | 4 | 10 |
| Splenomegaly | 16 | 10.8% | 1 | 5 |
| Haemoglobin decreased | 13 | 8.8% | 4 | 5 |
| Cardiac failure | 9 | 6.1% | 5 | 5 |
| Dyspnoea | 9 | 6.1% | 1 | 5 |
| Thrombocytopenia | 9 | 6.1% | 3 | 6 |
| Pyrexia | 8 | 5.4% | 3 | 5 |
| Fatigue | 7 | 4.7% | 2 | 3 |
| Myelofibrosis | 7 | 4.7% | 3 | 0 |
| Pain | 7 | 4.7% | 4 | 1 |
| Pneumonia | 7 | 4.7% | 2 | 4 |
| Asthenia | 6 | 4.1% | 2 | 4 |
| Drug ineffective | 6 | 4.1% | 0 | 1 |
Other Drugs Used for Myelofibrosis
RUXOLITINIB (21,650)
PACRITINIB (1,586)
JAKAFI (1,314)
FEDRATINIB (682)
MOMELOTINIB (526)
LENALIDOMIDE (496)
THALIDOMIDE (349)
DEFERASIROX (150)
HYDROXYUREA (129)
AZACITIDINE (94)